scholarly journals Phase I study of F16IL2 antibody–cytokine fusion with very low‐dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation

Author(s):  
Christoph Schliemann ◽  
Torsten Kessler ◽  
Andrew F. Berdel ◽  
Teresa Hemmerle ◽  
Linus Angenendt ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document